From earlier this month
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989707/
LAG3 and its emerging role in cancer immunotherapy
There are two types of LAG3‐targeting agents used as antitumor immunotherapies: LAG3 soluble dimeric recombinant protein named IMP321 and LAG3 mAb Or IMP321 v antibody universe.
Lines are being drawn for the scientific showdown in cancer immunotherapy. Stay tuned for the latest results.TABLE 1Clinical studies of LAG3 single‐targeted immunotherapy
- Forums
- ASX - By Stock
- IMM
- 90 cents is the price target
90 cents is the price target, page-54
-
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
33.3¢ |
Change
-0.023(6.34%) |
Mkt cap ! $479.3M |
Open | High | Low | Value | Volume |
34.0¢ | 34.5¢ | 32.5¢ | $952.6K | 2.840M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 179479 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.5¢ | 86244 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 181615 | 0.330 |
20 | 206374 | 0.325 |
14 | 85947 | 0.320 |
6 | 143571 | 0.315 |
8 | 64501 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.335 | 86339 | 18 |
0.340 | 98655 | 8 |
0.345 | 122093 | 7 |
0.350 | 91307 | 10 |
0.355 | 190434 | 10 |
Last trade - 11.34am 15/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |